Perivascular inflammation and hypertensive cardiovascular remodeling

Current Hypertension Reviews

Volumn 2, Issue 4, 2006, Pages 263-269

  Kai, Hisashi ^a   Kuwahara, Fumitaka ^a   Tokuda, Keisuke ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Hypertension; Inflammation; Macrophages; Myocardial fibrosis

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

AORTA CONSTRICTION; ARTERY WALL; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY; DISEASE ASSOCIATION; DRUG TARGETING; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INFLAMMATION; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT STRAIN; REVIEW; RISK FACTOR; UPREGULATION;

EID: 33750717532     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340206778742548     Document Type: Review

References (41)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Eng J Med 1990; 322: 1561-1565.
2. Narayan S, Janicki JS, Shroff SG, Pick R, Weber KT. Myocardial collagen and mechanics after preventing hypertrophy in hypertensive rats. Am J Hypertens 1989; 2: 675-682.
3. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OL. Myocardial fibrosis and stiffness with hypertrophy and heart failure in spontaneously hypertensive rats. Circulation 1995; 91: 161-170.
4. Matsubara LS, Matsubara BB, Okoshi MP, Cicogna AC, Janicki JS. Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol 2000; 279: H1534-H1539.
5. Yamamoto K, Masuyama T, Sakata Y, et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55: 76-82.
6. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993; 27: 341-348.
7. Nicoletti A, Michel JB. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 1999; 41: 532-543.
8. Sadoshima J, Izumi S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997; 59: 551-571.
9. Harada K, Komuro I, Shiojima I, et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 1999; 97: 1952-1959.
10. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rats. Cardiovasc Res 1992; 26: 671-677.
11. Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariety J, Michel JB. Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res 1996; 32: 1096-1107.
12. Kuwahara F, Kai H, Tokuda K, et al. Hypertensive myocardial fibrosis and diastolic dysfunction -Another model of inflammation. Hypertension 2004; 43: 739-745.
13. Ross R. Atherosclerosis: an inflammatory disease. N Eng J Med 1999; 340: 115-126.
14. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-1865.
15. Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130-135.
16. Hinglais N, Heudes D, Nicoletti A. Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 1994; 70: 286-294.
17. Komatsu S, Panes J, Russel JM, Anderson DC, Miyasaka M, Granger DN. Effects of chronic arterial hypertension on constitutive and induced intracellular adhesion molecule-1 expression in vivo. Hypertension 1997; 29: 683-689.
18. Shioi T, Matsumori A, Kihara Y, et al. Increased expression of interleukin-1β and monocyte chemotactic and activating factor /monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res 1997; 81: 664-671.
19. Kuwahara F, Kai H, Tokuda K, et al. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 2003; 41(2): 819-823.
20. Border WA, Nobel NA. Transforming growth factor-β in tissue fibrosis. N Eng J Med 1994; 331: 1286-1292.
21. Reap TJ, Groot PHE. Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213-225.
22. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Biol Chem 1993; 122: 103-111.
23. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspectives. Hypertens 1995; 25: 155-161.
24. Porreca E, DiFebbo C, Reale M, et al. Monocyte chemoattractant protein (MCP)-1 is a mitogen for cultured vascular smooth muscle cells. J Vasc Res 1997; 34: 58-65.
25. Jiang MJ, Yu YJ, Chen YL, Lee YM, Hung LS. Cyclic strain stimulates monocyte chemotactic protein-1 mRNA expression in smooth muscle cells. J Cell Biochem 1999; 76: 303-310.
26. Capers Q IV, Alexander RW, Lou P, et al. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997; 30: 1397-1402.
27. Kai H, Mori T, Tokuda K, et al. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II-. Hypertans Res 2006; 29: 711-718.
28. Tokuda K, Kai H, Kuwahara F, et al. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2004; 43: 499-503.
29. Tokuda K, Kai H, Kuwahara F, Imaizumi T. Sub-depressor dose of angiotensin type-1 receptor blocker inhibits TGF-β-mediated perivascular fibrosis in hypertensive rat hearts. J Cardiovasc Pharmacol 2003; 42 (suppl): S61-S65.
30. Mervaala EMA, Müller DN, Park J-K, et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999; 33[part II]: 389-395.
31. Pastore L, Tessitore A, Martinotti S, et al. Angiotensin II stimulates intracellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100: 1646-1652.
32. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998; 83: 952-959.
33. Hernandez-Presa M, Bustos C, Ortego M, et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95: 1532-1541.
34. Border WA, Ruoslahti E. Transforming growth factor-β in Disease: The dark side of tissue repair. J Clin Invest 1992; 90: 1-7.
35. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992; 120: 823-825.
36. Young M, Fullerton M, Dilley R, Funder J. Mineral corticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994; 93: 2578-2583.
37. Rocha R, Frierdich GE, Nachowiak DA, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002; 283: H1802-H1810.
38. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-1574.
39. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948-1955.
40. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-2289.
41. Kai H, Kuwahara F, Tokuda Y, Imaizumi T. Diastolic dysfunction in hypertensive hearts: Roles of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res 2005; 28: 483-490.